MARKET

BIIB

BIIB

Biogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

300.51
-3.96
-1.30%
After Hours: 300.51 0 0.00% 17:01 04/03 EDT
OPEN
303.70
PREV CLOSE
304.47
HIGH
311.53
LOW
296.81
VOLUME
1.42M
TURNOVER
--
52 WEEK HIGH
374.99
52 WEEK LOW
215.78
MARKET CAP
52.31B
P/E (TTM)
9.55
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 34 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BIIB stock price target is 335.17 with a high estimate of 420.00 and a low estimate of 245.00.

EPS

BIIB News

More
  • Berkshire's Unnoticed and Self-Beating Holdings
  • GuruFocus.com · 1d ago
  • 6 Health Care Companies Boosting Book Value
  • GuruFocus.com · 1d ago
  • Vertex enters new era of leadership, drug development
  • American City Business Journals · 1d ago
  • Why Biogen Shares Rose 2.59% in March
  • MotleyFool.com · 1d ago

Industry

Pharmaceuticals
-0.14%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About BIIB

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.
More

Webull offers kinds of Biogen Inc stock information, including NASDAQ:BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions.